Harry J. Leonhardt

2022 - Poseida Therapeutics

In 2022, Harry J. Leonhardt earned a total compensation of $978.3K as General Counsel, Chief Compliance Officer and Corporate Secretary at Poseida Therapeutics, a 32% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$188,690
Option Awards$177,109
Salary$428,833
Stock Awards$171,000
Other$12,710
Total$978,342

Leonhardt received $428.8K in salary, accounting for 44% of the total pay in 2022.

Leonhardt also received $188.7K in non-equity incentive plan, $177.1K in option awards, $171K in stock awards and $12.7K in other compensation.

Rankings

In 2022, Harry J. Leonhardt's compensation ranked 3,073rd out of 5,733 executives tracked by ExecPay. In other words, Leonhardt earned more than 46.4% of executives.

ClassificationRankingPercentile
All
3,073
out of 5,733
46th
Division
Manufacturing
1,731
out of 3,122
45th
Major group
Chemicals And Allied Products
815
out of 1,416
42nd
Industry group
Drugs
761
out of 1,317
42nd
Industry
Biological Products, Except Diagnostic Substances
185
out of 291
36th
Source: SEC filing on April 26, 2023.

Leonhardt's colleagues

We found three more compensation records of executives who worked with Harry J. Leonhardt at Poseida Therapeutics in 2022.

2022

Mark Gergen

Poseida Therapeutics

Chief Executive Officer

2022

Brent Warner

Poseida Therapeutics

President, Gene Therapy

2022

Eric Ostertag

Poseida Therapeutics

Chief Executive Officer

News

You may also like